| Zhong, Wei |
NCT05688696: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus |
|
|
| Recruiting | 2b | 186 | RoW | Orelabrutinib (Low Dose), Orelabrutinib (High Dose), Orelabrutinib Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Systemic Lupus Erythematosus, SLE | 05/24 | 05/25 | | |
NCT03215693: X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib |
|
|
| Active, not recruiting | 2 | 152 | RoW | X-396 capsule, Ensartinib | Betta Pharmaceuticals Co., Ltd. | Non-Small Cell Lung Cancer | 03/20 | 12/23 | | |
| Recruiting | 2 | 37 | RoW | Sintilimab | Peking Union Medical College Hospital | Carcinoma, Non-Small Cell Lung | 04/22 | 04/23 | | |
NCT05899725: The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia |
|
|
| Recruiting | N/A | 60 | RoW | Corticosteroids, Corticosteroids and Ruxolitinib | Peking Union Medical College Hospital | Severe Checkpoint Inhibitor Pneumonitis | 03/25 | 06/25 | | |
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. |
|
|
| Recruiting | N/A | 244 | RoW | Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale, Cryptogenic Stroke | 04/25 | 06/29 | | |
NCT03398629: Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies |
|
|
| Recruiting | N/A | 10000 | RoW | | Guangzhou Women and Children's Medical Center | Intrauterine Growth Restriction, Fetal Anomaly, Chromosomal Anomalies, Pregnancy | 03/38 | 03/38 | | |
| Zhong, Zhixiong |
NCT06471218: Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia |
|
|
| Not yet recruiting | 2 | 42 | RoW | SHR-1918; SHR-1918 Placebo | Beijing Suncadia Pharmaceuticals Co., Ltd | Hyperlipidemia | 04/25 | 06/25 | | |
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis |
|
|
| Completed | N/A | 260 | RoW | drug-coated balloon Catheter | B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease, In Stent Restenosis | 07/22 | 08/22 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. |
|
|
| Recruiting | N/A | 244 | RoW | Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale, Cryptogenic Stroke | 04/25 | 06/29 | | |
NCT06024525: Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide® |
|
|
| Not yet recruiting | N/A | 236 | RoW | Paclitaxel-Coated Coronary Balloon Catheters, Paclitaxel-Releasing Coronary Balloon Catheters | Shanghai Shenqi Medical Technology Co., Ltd | Coronary Artery Disease | 06/25 | 06/26 | | |
| Yang, Fayou |
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. |
|
|
| Recruiting | N/A | 244 | RoW | Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale, Cryptogenic Stroke | 04/25 | 06/29 | | |
